Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 26 December, 2024
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 524212 | NSE: WANBURY

Wanbury Ltd: Fundamental Analysis, Share Price Insights & Intrinsic Value (2024)

Share Price and Basic Stock Data

Last Updated: December 26, 2024, 9:26 pm

Market Cap 877 Cr.
Current Price 267
High / Low 325/122
Stock P/E31.8
Book Value 11.8
Dividend Yield0.00 %
ROCE60.6 %
ROE%
Face Value 10.0
PEG Ratio0.37

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Wanbury Ltd

Competitors of Wanbury Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
MPS Pharmaa Ltd 8.20 Cr. 4.29 4.33/2.79 0.800.00 %9.15 %34.9 % 10.0
Gujarat Themis Biosyn Ltd 3,352 Cr. 308 390/14763.6 20.50.22 %45.0 %33.8 % 1.00
Gujarat Terce Laboratories Ltd 60.9 Cr. 82.1 94.9/26.623.3 11.90.00 %9.72 %3.44 % 10.0
Gujarat Inject (Kerala) Ltd 34.4 Cr. 23.4 27.0/8.7444.6 6.640.00 %2.65 %2.08 % 10.0
Godavari Drugs Ltd 87.5 Cr. 116 155/87.013.1 55.40.00 %14.4 %15.5 % 10.0
Industry Average19,110.67 Cr1,166.2154.93184.740.32%16.14%16.48%6.30

All Competitor Stocks of Wanbury Ltd

Quarterly Result

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Sales120128124125134117124126133146144146139
Expenses122121117116122120118119119133127124121
Operating Profit-277913-3661413172118
OPM %-1%5%6%7%10%-3%5%5%11%9%12%15%13%
Other Income100077210-311126
Interest6556534786887
Depreciation3333333333333
Profit before tax-9-1-1082-7-1-31571034
Tax %0%7%11%14%-1%-3%25%8%-11%6%-2%-0%1%
Net Profit-9-1-1083-7-1-31571034
EPS in Rs-3.58-0.26-0.180.1125.27-2.21-0.27-1.000.311.432.253.1410.27

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthMar 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales459661250420432370391367392511500576560
Expenses491637228387414438375344374475476506493
Operating Profit-3225213319-6816231836237068
OPM %-7%4%9%8%4%-18%4%6%5%7%5%12%12%
Other Income5-7860907698427702929
Interest37481932363140332321212931
Depreciation232359101010101011121313
Profit before tax-87-1254-762-32-2565-1281-105652
Tax %0%2%28%0%1%-1%-1%0%2%-0%1%1%
Net Profit-87-1283-762-32-2564-1381-105652
EPS in Rs-50.19-63.951.60-3.5826.71-13.49-10.4825.79-5.0424.94-3.1817.0915.98
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-47.13%-333.33%985.71%-151.61%21.88%356.00%-120.31%723.08%-112.35%660.00%
Change in YoY Net Profit Growth (%)0.00%-286.21%1319.05%-1137.33%173.49%334.12%-476.31%843.39%-835.42%772.35%

Wanbury Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:%
5 Years:7%
3 Years:12%
TTM:5%
Compounded Profit Growth
10 Years:%
5 Years:27%
3 Years:68%
TTM:166%
Stock Price CAGR
10 Years:25%
5 Years:70%
3 Years:45%
1 Year:108%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:27 pm

MonthMar 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital17202020232424252533333333
Reserves-65-212-214-209-176-208-233-168-181-56-66-56
Borrowings41538938136230025026019019210095116181
Other Liabilities406209209215265207236232253276241199177
Total Liabilities773406396388412273286279289353304343397
Fixed Assets423174164180186178172164167167167167165
CWIP2513191410109141122316
Investments1000000000002
Other Assets32421921319321684105101111183135174214
Total Assets773406396388412273286279289353304343397

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +87684043433230441741204
Cash from Investing Activity +-21-6-5-20-13-1-36481-9-17
Cash from Financing Activity +-64-71-30-28-27-33-27-108-17-29-3215
Net Cash Flow3-95-53-2-0-0713-212

Free Cash Flow

MonthMar 2013Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2014
Free Cash Flow-447.00-360.00-329.00-281.00-318.00-244.00-167.00-174.00-64.00-72.00-46.00-364.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Sep 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days6757144657129415032455259
Inventory Days6342103696327362541602643
Days Payable114113301172260174209253221218179196
Cash Conversion Cycle15-14-55-38-125-118-131-177-148-113-101-94
Working Capital Days-159-3-26-45-132-195-175-212-168-103-102-20
ROCE %-11%4%12%57%-1%26%31%27%46%21%62%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters39.90%39.89%39.89%39.85%39.85%39.84%39.84%39.84%39.80%39.79%39.79%39.79%
FIIs0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.22%
DIIs0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public60.09%60.11%60.11%60.15%60.16%60.16%60.16%60.16%60.19%60.20%60.02%59.97%
No. of Shareholders11,58111,61911,28911,39811,55511,88811,91111,74111,63411,61613,08714,400

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)17.10-3.1825.29-5.0426.90
Diluted EPS (Rs.)16.89-3.1825.21-5.0426.90
Cash EPS (Rs.)21.070.6028.45-1.1429.66
Book Value[Excl.RevalReserv]/Share (Rs.)8.53-10.03-7.17-62.46-57.39
Book Value[Incl.RevalReserv]/Share (Rs.)8.53-10.03-7.17-62.46-57.39
Revenue From Operations / Share (Rs.)175.79152.77156.49156.91147.01
PBDIT / Share (Rs.)22.297.3611.278.169.84
PBIT / Share (Rs.)18.313.587.774.265.96
PBT / Share (Rs.)17.20-3.1524.84-4.9625.87
Net Profit / Share (Rs.)17.09-3.1824.94-5.0425.79
NP After MI And SOA / Share (Rs.)17.09-3.1824.94-5.0425.79
PBDIT Margin (%)12.674.827.205.206.69
PBIT Margin (%)10.412.344.962.714.05
PBT Margin (%)9.78-2.0515.87-3.1617.59
Net Profit Margin (%)9.72-2.0815.93-3.2117.54
NP After MI And SOA Margin (%)9.72-2.0815.93-3.2117.54
Return on Networth / Equity (%)200.260.00-347.880.00-44.93
Return on Capital Employeed (%)46.34-70.89-351.22-16.12-46.06
Return On Assets (%)16.29-3.4223.10-4.3523.13
Long Term Debt / Equity (X)2.930.000.00-0.46-0.69
Total Debt / Equity (X)3.94-1.95-2.86-0.56-0.86
Asset Turnover Ratio (%)1.781.521.601.391.30
Current Ratio (X)0.740.380.480.280.30
Quick Ratio (X)0.570.310.340.210.26
Inventory Turnover Ratio (X)9.977.188.1811.529.27
Interest Coverage Ratio (X)2.501.131.790.880.74
Interest Coverage Ratio (Post Tax) (X)2.040.541.250.450.44
Enterprise Value (Cr.)581.65182.26319.37284.21153.26
EV / Net Operating Revenue (X)1.010.360.620.720.41
EV / EBITDA (X)7.977.578.6713.926.23
MarketCap / Net Operating Revenue (X)0.820.240.540.520.12
Price / BV (X)17.09-3.72-11.86-1.33-0.31
Price / Net Operating Revenue (X)0.820.240.540.520.12
EarningsYield0.11-0.080.29-0.061.42

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Wanbury Ltd as of December 26, 2024 is: 57.41

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of December 26, 2024, Wanbury Ltd is Overvalued by 78.50% compared to the current share price 267.00

Default values used*: Default value of 15% for ROE is used

Intrinsic Value of Wanbury Ltd as of December 26, 2024 is: 106.55

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of December 26, 2024, Wanbury Ltd is Overvalued by 60.09% compared to the current share price 267.00

Default values used*: Default value of 15% for ROE is used

Last 5 Year EPS CAGR: 85.59%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 22.83%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -111.67, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -91.58, which is a positive sign.
  4. The company has shown consistent growth in sales (453.00 cr) and profit (1.69 cr) over the years.
  1. The company has higher borrowings (248.54) compared to reserves (-137.46), which may suggest financial risk.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Wanbury Ltd:
    1. Net Profit Margin: 9.72%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 46.34% (Industry Average ROCE: 16.01%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 200.26% (Industry Average ROE: 15.93%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 2.04
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.57
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 31.8 (Industry average Stock P/E: 44.77)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 3.94
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 511.19 Cr. and Equity Capital is Rs. 32.67 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsBSEL Tech Park, B-Wing, 10th Floor, Sector 30-A, New Mumbai Maharashtra 400703cs@wanbury.com
http://www.wanbury.com
Management
NamePosition Held
Mr. K ChandranVice Chairman & Whole Time Dir
Ms. Anupama VaidyaInd. Non-Executive Woman Director
Mr. Mohan Kumar RayanaWhole Time Director
Mr. Pravin Dilip PawarInd. Non-Executive Director
Mr. Mridul Sumanlal MehtaAddnl.Non Exe.Independent Director

FAQ

What is the latest intrinsic value of Wanbury Ltd?

The latest intrinsic value of Wanbury Ltd as on 26 December 2024 is ₹57.41, which is 78.50% lower than the current market price of ₹267.00. The stock has a market capitalization of 877 Cr. and recorded a high/low of 325/122 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹6 Cr and total liabilities of ₹397 Cr.

What is the Market Cap of Wanbury Ltd?

The Market Cap of Wanbury Ltd is 877 Cr..

What is the current Stock Price of Wanbury Ltd as on 26 December 2024?

The current stock price of Wanbury Ltd as on 26 December 2024 is 267.

What is the High / Low of Wanbury Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Wanbury Ltd stocks is 325/122.

What is the Stock P/E of Wanbury Ltd?

The Stock P/E of Wanbury Ltd is 31.8.

What is the Book Value of Wanbury Ltd?

The Book Value of Wanbury Ltd is 11.8.

What is the Dividend Yield of Wanbury Ltd?

The Dividend Yield of Wanbury Ltd is 0.00 %.

What is the ROCE of Wanbury Ltd?

The ROCE of Wanbury Ltd is 60.6 %.

What is the ROE of Wanbury Ltd?

The ROE of Wanbury Ltd is %.

What is the Face Value of Wanbury Ltd?

The Face Value of Wanbury Ltd is 10.0.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Wanbury Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE